Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1997 May;90(5):274–275. doi: 10.1177/014107689709000512

Non-Hodgkin lymphoma with panhypopituitarism, hyperprolactinaemia and sixth nerve palsy.

J A Shaw 1, F M Strachan 1, H A Sawers 1, J S Bevan 1
PMCID: PMC1296264  PMID: 9204025

Full text

PDF
274

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bevan J. S., Burke C. W., Esiri M. M., Adams C. B. Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement. Am J Med. 1987 Jan;82(1):29–32. doi: 10.1016/0002-9343(87)90373-1. [DOI] [PubMed] [Google Scholar]
  2. Fine H. A., Mayer R. J. Primary central nervous system lymphoma. Ann Intern Med. 1993 Dec 1;119(11):1093–1104. doi: 10.7326/0003-4819-119-11-199312010-00007. [DOI] [PubMed] [Google Scholar]
  3. Gellersen B., DiMattia G. E., Friesen H. G., Bohnet H. G. Regulation of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion. Endocrinology. 1989 Dec;125(6):2853–2861. doi: 10.1210/endo-125-6-2853. [DOI] [PubMed] [Google Scholar]
  4. Grobe N., Rühle H., Eckelmann G. Hyperprolactinämie bei malignen Lymphomen. Dtsch Med Wochenschr. 1990 Nov 30;115(48):1825–1827. doi: 10.1055/s-2008-1065232. [DOI] [PubMed] [Google Scholar]
  5. Jonkhoff A. R., Huijgens P. C., Schreuder W. O., Teule G. J., Heimans J. J. Hypophyseal non-Hodgkin's lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy. J Neurooncol. 1993 Aug;17(2):155–158. doi: 10.1007/BF01050217. [DOI] [PubMed] [Google Scholar]
  6. Lundberg P. O., Osterman P. O., Wide L. Serum prolactin in patients with hypothalamus and pituitary disorders. J Neurosurg. 1981 Aug;55(2):194–199. doi: 10.3171/jns.1981.55.2.0194. [DOI] [PubMed] [Google Scholar]
  7. Pellegrini I., Lebrun J. J., Ali S., Kelly P. A. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol. 1992 Jul;6(7):1023–1031. doi: 10.1210/mend.6.7.1508218. [DOI] [PubMed] [Google Scholar]
  8. Rillema J. A., Lawson D. M. Identification of two specific prolactin binding sites on Nb2 rat lymphoma cells. Proc Soc Exp Biol Med. 1994 Jan;205(1):75–79. doi: 10.3181/00379727-205-43680. [DOI] [PubMed] [Google Scholar]
  9. Ross R. J., Grossman A., Bouloux P., Rees L. H., Doniach I., Besser G. M. The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clin Endocrinol (Oxf) 1985 Sep;23(3):227–235. doi: 10.1111/j.1365-2265.1985.tb00218.x. [DOI] [PubMed] [Google Scholar]
  10. Teears R. J., Silverman E. M. Clinicopathologic review of 88 cases of carcinoma metastatic to the putuitary gland. Cancer. 1975 Jul;36(1):216–220. doi: 10.1002/1097-0142(197507)36:1<216::aid-cncr2820360123>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES